New sedative aims to ease ventilator discomfort in ICU patients

NCT ID NCT07372924

Recruiting now Symptom relief Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Feb 01, 2026 · Last updated May 18, 2026 · Updated 15 times

Summary

This study tests a new sedative called tegileridine fumarate for patients in the intensive care unit (ICU) who need a breathing machine (ventilator) for 2 to 3 days. The goal is to keep patients calm and comfortable while on the ventilator. About 120 adults will take part, and the study compares different doses of the new drug to a standard sedative to see which works best and is safest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABIRRITATION IN THE ICU are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Hubei, Wuhan, 430015, China

Contact
Zhongshan Hospital
RECRUITING

Shanghai, Shanghai Municipality, 200030, China

Contact

Conditions

Explore the condition pages connected to this study.

ABIRRITATION IN THE ICU